SlideShare a Scribd company logo
1 of 24
A Simulated Diabetes Learning
Intervention Improves Provider
 Knowledge and Confidence in
      Managing Diabetes
                    JoAnn Sperl-Hillen, MD
          Co-director of Center for Chronic Care Innovation
        HealthPartners Research Foundation, Minneapolis, MN

                 Wednesday May 2, 2012 8-9:30am
           18th Annual HMO Research Network Conference
                            Seattle, WA


Accelerating excellence in health performance
through education, advocacy, and collaboration
Team Members
   JoAnn Sperl-Hillen                   Steve Asche
   Patrick O’Connor                     George Biltz*
   Heidi Ekstrom                        Deb Curran
   William Rush                         Paul Johnson*
   Omar Fernandes                       Andrew Rudge
   Jerry Amundson                       Todd Gilmer**
   Deepika Appana
    HealthPartners Research Foundation and HealthPartners
    Institute for Medical Education, Minneapolis, MN;
    * Carlson School of Management, University of
    Minnesota, Minneapolis MN;
    ** Department of Family and Preventive Medicine, University
    of California, San Diego, La Jolla, CA
Presenter Disclosures

   NIH research support
   Listed inventor on a U.S. patent application filed
    related to simulation technology
   HPRF has recently entered into a royalty-bearing
    license agreement with a third party to commercialize
    the simulated learning technology for the purpose of
    broader dissemination.
   Non-paid director on the board of directors for that
    licensee (SimCare Health)
Why is provider training
            needed?
 Provider performance varies, even
  within the same clinic populations
 Clinical inertia is common, particularly
  for insulin treatment
 Provider knowledge varies

 The cognitive processes and tasks
  related to diabetes are complex
Barriers to Provider Training

 Time constraints
 Lack of continuity experiences

 Relatively limited ambulatory
  experience in residency training
 Complicated diseases with need for
  personalization of care
 Experts & opinion leaders are often not
  available or affordable, and teaching is
  difficult to standardize
What is simulation?
―Simulation is a technique—not a technology—to replace
or amplify real experiences with guided experiences that
evoke or replicate substantial aspects of the real world in
a fully interactive manner.‖ Gaba (2004)

               History of Simulation
   Aviation
   NASA
   Military
   Medical
       1960s First Mannequin: Resusci-Annie
       1960s-70s Computer-assisted learning program in
       medicine
       1990 High fidelity mannequins become available
What are the advantages to
          simulation?
   Efficient & cost effective
   Sustainable & standardized
   In line with adult learning principles
   Personalized (case-based). Case-based
    simulations provide a context for learning
   People are more likely to remember learning
    and replicate in real-world situations.
   Capture the importance of continuity of care
   Proven satisfaction & effectiveness
Elements needed to create a
  simulated learning program
1. Identify the learning needs and
  create a library of case scenarios
2. Create an interactive web-interface
3. Model and program the physiology
4. Program the feedback – to critique
  action the provider takes between
  encounters
Demo of SimCare available at www.simcarediabetes.org

    Patient “snapshot” screen shot
Visit navigator screen shot
Feedback between every encounter
Early SimCare Study
Funding through R01HS10639, Physician Intervention to Improve Diabetes Care
   57 consented PCP’s and their 2,020 patients.
   Randomized to one of 3 groups:
         (A) no intervention

         (B) learning intervention (SimCare) consisting
          of 3 simulated learning cases (1 hr)
         (C) SimCare + physician opinion leader

   Results:
         SimCare reduced risky prescribing of
          metformin in patients with renal impairment
          (p=0.03).
         Group B (SimCare alone) achieved slightly
          better glycemic control than A or C (p=.04)
SimCare Version 2
     Funding through R01DK068314, Reducing Clinical Inertia in Diabetes

   Eleven clinics with 41 consenting PCP’s

   Randomized to receive or not receive an
    improved version of SimCare (12 cases
    assigned based on profiled ―needs‖, 3 hrs)

   Results: Patients of intervention providers
    with baseline A1c > 7% had significantly
    greater A1c reduction (-.19%) relative to
    patients of non-intervention providers.
SimCare Version 3
Funding through R18DK079861, Simulated Diabetes Training for Resident Physicians

                                           19 eligible residency programs
                                               linked to 723 residents

                                                                            382 residents did
                                                                              not consent
                                             341 residents consented



                              Intervention – Early learning 10)    Control – Late learning (9)
                                      Residents (177)                  Residents (164)



                                    Completion rates
                                                                          Completion rates
                                  Learning cases (142)
                                                                       Assessment cases (135)
                                 Assessment cases (97)
                                                                       Knowledge survey (128)
                                 Knowledge survey (92)
                                    Evaluation (94)
Implementing the learning program
   Residents at 19 programs were given a brochure that
    we provided and asked to sign up online
   Resident participation was voluntary.
   Time commitment – 18 cases, 1 hour/month for 8
    months if randomized to the early intervention group
   Incentives - $50 Target gift card on completion of the
    assigned tasks
   Promotions – 4 iPad raffle promotions and 1 Target
    gift card promotion to achieve acceptable learning
    and assessment case completion rates
Baseline characteristics of residents
                           Intervention   Control
                                                    P-value
                              (n=92)      (n=128)
% female                      48%          57%       0.31
% white                       48%          58%       0.41
Age (median)                   29           29       0.69
Specialty
 Family Medicine              34%          49%
 Internal Medicine            54%          42%       0.15
 Med-Peds                     8%           7%
 Other                        4%           2%

Post graduate year
                              35%          34%
 1
                              36%          34%
 2                                                   0.70
                              28%          28%
 3
                              1%           4%
 4
Example Knowledge Question
2. A 77 year old black man is seeing you for follow up. He has a 13 year history of type 2
diabetes, coronary heart disease (CABG at age 58), chronic stable angina, and
dyslipidemia. He has been eating out a lot and gaining weight. His current medications are
metformin 1000 mg bid, atenolol 50 mg qd, and simvastatin 40 mg qd. His BMI is 37, BP is
165/86, A1c 9.3%, Cr 2. 2 mg/dl, eGFR 28, LDL 94 mg/dl, HDL 36 mg/dl, and TG 278
mg/dl.

Which of the following would be your MOST likely recommended action?

A. Start basal insulin and treat to an A1c goal of < 7%. No change in other glycemia
medications.
B. Discontinue metformin and start basal insulin. Follow up with patient for insulin
adjustments with an A1c goal of < 7%.
C. Start basal insulin and follow up with the patient for insulin adjustments with an A1c goal
of < 8%. No change in other glycemia medications.
D. Discontinue metformin and start basal insulin. Follow up with patient for insulin
adjustments with an A1c goal of < 8%.
E. No change now because I would address other patient problems

   Correct answer D (59% intervention, 26% control)
P-
Q#                    Knowledge topics covered                           Early   Late
                                                                                        value
1                    Screen for DM (using an A1c)                        75.0    75.8    .894

2           Basal insulin start, individualized A1c goal < 8%            58.7    25.8   <.0001

      Check ketones in newly diagnosed symptomatic patients &
3                                                                        31.5    28.1    .586
                            start insulin
         Reduce basal insulin due to nocturnal hypoglycemia
4                                                                        64.1    70.3    .333
                             (Somogyii)
5        Relax A1c target due to hypoglycemia unawareness                57.6    32.8   .0002

6       Start insulin in a newly diagnosed symptomatic patient           33.7    11.7   <.0001

     Use of a loop diuretic rather than thiazide in patient with renal
7     insufficiency. Fenofibrate not beneficial in addition to statin.   44.6    19.5   <.0001
               DC metformin due to renal contraindication.

      Initiate BP tx (without confirmatory testing) if BP > 180/100.
8                                                                        59.8    44.5   0.026
            Statins may be helpful for most patients with DM.

9       Start a statin, screen for depression, basal insulin start       66.3    57.0    .164

       Geriatric polypharmacy concerns, depression screening,
10                                                                       46.7    41.4    .431
        hypoglycemia management, statin use in the elderly
Results of Knowledge Testing

Number of items
                     Intervention       Control
correct out of 10

       0-4               29%              66%

       5-7               60%              32%

      8-10                11%             2%



  Mean score              5.31             4.10
                                                     p < .001
   (95% CI)           (4.87-5.75)      (3.69-4.50)


N=220 completers of knowledge survey
Results of self-rated confidence and
   knowledge about diabetes management

                  Topic                       Intervention   Control   P-value

How knowledgeable are you about how to
use all available drug classes to manage          61           25      <.001
         patients with diabetes?
How knowledgeable are you about how to
                                                  83           45      <.001
       start and adjust insulin?
    How knowledgeable are you about
interpreting patient self-monitored glucose       85           59       .009
             values (SMBGs)?
How knowledgeable are you about setting
individualized treatment goals for people         83           44      <.001
              with diabetes?
How confident are you in managing patients
                                                  79           44      <.001
              with diabetes?
Evidence for learning transfer
               to actual patient care
   77% applied learning to actual patients
   63% shortened visit intervals
   78% more likely to add or increase drugs if patient is
    not at goal
   92% more confident about insulin use in actual
    patients

     ….and results of two trials had demonstrated improved outcomes
     of actual patients of practicing providers who used earlier
     versions of SimCare
Study limitations

   Voluntary participation, not all completed the learning
    program and completed evaluations
   No outcome data on non-completers
   Survey completion rates were lower in the intervention
    (52%) than the control groups (78%)
   No actual patient data to evaluate
   Assessment case outcomes not yet available
Thank you! For additional questions, please
                    contact…

   JoAnn Sperl-Hillen:
    joann.m.sperlhillen@healthpartners.com
   Patrick O’Connor:
    patrick.j.oconnor@healthpartners.com
   Heidi Ekstrom:
    heidi.l.ekstrom@healthpartners.com
Talk References
   Simulated Physician Learning Intervention to
    Improve Safety and Quality of Diabetes Care: A
    Randomized Trial
      O’Connor PJ, Sperl-Hillen JM, et al. Simulated physician
      learning intervention to improve safety and quality of diabetes
      care: A Randomized Trial. Diabetes Care. 2009;32(4): 585-590.


   Simulated Physician Learning Program Improves
    Glucose Control in Adults with Diabetes
      Sperl-Hillen JM, O’Connor PJ, Rush WA, Johnson PE, Gilmer
      TP, Biltz G, Asche SE, Ekstrom HL. Simulated Physician
      Learning Program Improves Glucose Control in Adults with
      Diabetes. Diabetes Care. 2010;33(8): 1727-1733.

More Related Content

What's hot

PRIDE-HD on behalf of the HSG PRIDE-HD Investigators
PRIDE-HD on behalf of the HSG PRIDE-HD InvestigatorsPRIDE-HD on behalf of the HSG PRIDE-HD Investigators
PRIDE-HD on behalf of the HSG PRIDE-HD InvestigatorsHuntington Study Group
 
Digital Biomarkers for Huntington Disease
Digital Biomarkers for Huntington DiseaseDigital Biomarkers for Huntington Disease
Digital Biomarkers for Huntington DiseaseHuntington Study Group
 
Bogota delirium051110
Bogota delirium051110Bogota delirium051110
Bogota delirium051110hospira2010
 
Journal club222 EEG as predictive tool for development
Journal club222 EEG as predictive tool for developmentJournal club222 EEG as predictive tool for development
Journal club222 EEG as predictive tool for developmentYassin Alsaleh
 
G082 Ito, T., Kodaira, T., Matsugami, S., & Inoue (2008). Schizophrenia prej...
G082  Ito, T., Kodaira, T., Matsugami, S., & Inoue (2008). Schizophrenia prej...G082  Ito, T., Kodaira, T., Matsugami, S., & Inoue (2008). Schizophrenia prej...
G082 Ito, T., Kodaira, T., Matsugami, S., & Inoue (2008). Schizophrenia prej...Takehiko Ito
 
PT Mx for NCCP (latest)
PT Mx for NCCP (latest)PT Mx for NCCP (latest)
PT Mx for NCCP (latest)Guojie Lian
 
T Sornasse Elan Chi Accelerating Proof Of Concept 2010
T Sornasse Elan Chi Accelerating Proof Of Concept 2010T Sornasse Elan Chi Accelerating Proof Of Concept 2010
T Sornasse Elan Chi Accelerating Proof Of Concept 2010tsornasse
 
The best of_the_pem_literature_in_the_last_year_terry_klassen_presentation
The best of_the_pem_literature_in_the_last_year_terry_klassen_presentationThe best of_the_pem_literature_in_the_last_year_terry_klassen_presentation
The best of_the_pem_literature_in_the_last_year_terry_klassen_presentationtrekkca
 
G093 Kodaira, T., Ito, T., Matsugami, S., & Inoue (2008). Can we reduce the ...
G093  Kodaira, T., Ito, T., Matsugami, S., & Inoue (2008). Can we reduce the ...G093  Kodaira, T., Ito, T., Matsugami, S., & Inoue (2008). Can we reduce the ...
G093 Kodaira, T., Ito, T., Matsugami, S., & Inoue (2008). Can we reduce the ...Takehiko Ito
 
Low Back Pain Clinical Practice Guideline
Low Back Pain Clinical Practice GuidelineLow Back Pain Clinical Practice Guideline
Low Back Pain Clinical Practice GuidelineMr. Saeed Al-Amri
 
IMPROVING PERFORMANCE OF ALGORITHMS TO POWER UNMET NEED AND EFFECTIVENESS IN ...
IMPROVING PERFORMANCE OF ALGORITHMS TO POWER UNMET NEED AND EFFECTIVENESS IN ...IMPROVING PERFORMANCE OF ALGORITHMS TO POWER UNMET NEED AND EFFECTIVENESS IN ...
IMPROVING PERFORMANCE OF ALGORITHMS TO POWER UNMET NEED AND EFFECTIVENESS IN ...Schiffon Wong
 

What's hot (18)

PRIDE-HD on behalf of the HSG PRIDE-HD Investigators
PRIDE-HD on behalf of the HSG PRIDE-HD InvestigatorsPRIDE-HD on behalf of the HSG PRIDE-HD Investigators
PRIDE-HD on behalf of the HSG PRIDE-HD Investigators
 
Digital Biomarkers for Huntington Disease
Digital Biomarkers for Huntington DiseaseDigital Biomarkers for Huntington Disease
Digital Biomarkers for Huntington Disease
 
Bogota delirium051110
Bogota delirium051110Bogota delirium051110
Bogota delirium051110
 
Journal club222 EEG as predictive tool for development
Journal club222 EEG as predictive tool for developmentJournal club222 EEG as predictive tool for development
Journal club222 EEG as predictive tool for development
 
G082 Ito, T., Kodaira, T., Matsugami, S., & Inoue (2008). Schizophrenia prej...
G082  Ito, T., Kodaira, T., Matsugami, S., & Inoue (2008). Schizophrenia prej...G082  Ito, T., Kodaira, T., Matsugami, S., & Inoue (2008). Schizophrenia prej...
G082 Ito, T., Kodaira, T., Matsugami, S., & Inoue (2008). Schizophrenia prej...
 
Age reversing modalities
Age reversing modalitiesAge reversing modalities
Age reversing modalities
 
Spotlight on Vanderbilt University
Spotlight on Vanderbilt UniversitySpotlight on Vanderbilt University
Spotlight on Vanderbilt University
 
PT Mx for NCCP (latest)
PT Mx for NCCP (latest)PT Mx for NCCP (latest)
PT Mx for NCCP (latest)
 
T Sornasse Elan Chi Accelerating Proof Of Concept 2010
T Sornasse Elan Chi Accelerating Proof Of Concept 2010T Sornasse Elan Chi Accelerating Proof Of Concept 2010
T Sornasse Elan Chi Accelerating Proof Of Concept 2010
 
The best of_the_pem_literature_in_the_last_year_terry_klassen_presentation
The best of_the_pem_literature_in_the_last_year_terry_klassen_presentationThe best of_the_pem_literature_in_the_last_year_terry_klassen_presentation
The best of_the_pem_literature_in_the_last_year_terry_klassen_presentation
 
Patient Safety – The Danish Experience
Patient Safety – The Danish ExperiencePatient Safety – The Danish Experience
Patient Safety – The Danish Experience
 
G093 Kodaira, T., Ito, T., Matsugami, S., & Inoue (2008). Can we reduce the ...
G093  Kodaira, T., Ito, T., Matsugami, S., & Inoue (2008). Can we reduce the ...G093  Kodaira, T., Ito, T., Matsugami, S., & Inoue (2008). Can we reduce the ...
G093 Kodaira, T., Ito, T., Matsugami, S., & Inoue (2008). Can we reduce the ...
 
Low Back Pain Clinical Practice Guideline
Low Back Pain Clinical Practice GuidelineLow Back Pain Clinical Practice Guideline
Low Back Pain Clinical Practice Guideline
 
Neurosearch - Kapitalmarkedsdag marts 2012
Neurosearch - Kapitalmarkedsdag marts 2012Neurosearch - Kapitalmarkedsdag marts 2012
Neurosearch - Kapitalmarkedsdag marts 2012
 
Tb guideline 2010
Tb guideline 2010Tb guideline 2010
Tb guideline 2010
 
IMPROVING PERFORMANCE OF ALGORITHMS TO POWER UNMET NEED AND EFFECTIVENESS IN ...
IMPROVING PERFORMANCE OF ALGORITHMS TO POWER UNMET NEED AND EFFECTIVENESS IN ...IMPROVING PERFORMANCE OF ALGORITHMS TO POWER UNMET NEED AND EFFECTIVENESS IN ...
IMPROVING PERFORMANCE OF ALGORITHMS TO POWER UNMET NEED AND EFFECTIVENESS IN ...
 
The burden of epilepsy
The burden of epilepsyThe burden of epilepsy
The burden of epilepsy
 
Datashow
DatashowDatashow
Datashow
 

Viewers also liked

Online Patient Access to their Medical Record and Health Providers is Associa...
Online Patient Access to their Medical Record and Health Providers is Associa...Online Patient Access to their Medical Record and Health Providers is Associa...
Online Patient Access to their Medical Record and Health Providers is Associa...HMO Research Network
 
I Got Mine Have you Gotten Yours Email to Promote Colorectal Cancer Screening...
I Got Mine Have you Gotten Yours Email to Promote Colorectal Cancer Screening...I Got Mine Have you Gotten Yours Email to Promote Colorectal Cancer Screening...
I Got Mine Have you Gotten Yours Email to Promote Colorectal Cancer Screening...HMO Research Network
 
Use of the Oncology Beacon Module snd Virtusl Dats Warehouse Data to Identify...
Use of the Oncology Beacon Module snd Virtusl Dats Warehouse Data to Identify...Use of the Oncology Beacon Module snd Virtusl Dats Warehouse Data to Identify...
Use of the Oncology Beacon Module snd Virtusl Dats Warehouse Data to Identify...HMO Research Network
 
Trend Micro Titanium Antivirus 2012 Review
Trend Micro Titanium Antivirus 2012 ReviewTrend Micro Titanium Antivirus 2012 Review
Trend Micro Titanium Antivirus 2012 Reviewstakro
 
How to find the Right Contracts & the Right People to Fill Them: Part 4 - Co...
How to find the Right Contracts & the Right People to Fill Them:  Part 4 - Co...How to find the Right Contracts & the Right People to Fill Them:  Part 4 - Co...
How to find the Right Contracts & the Right People to Fill Them: Part 4 - Co...Amy Schumacher
 
How Important Is Your Blog Design?
How Important Is Your Blog Design?How Important Is Your Blog Design?
How Important Is Your Blog Design?stakro
 
Generalized Anxiety and Depression Among Chronic Pain Patients on Opiod Thera...
Generalized Anxiety and Depression Among Chronic Pain Patients on Opiod Thera...Generalized Anxiety and Depression Among Chronic Pain Patients on Opiod Thera...
Generalized Anxiety and Depression Among Chronic Pain Patients on Opiod Thera...HMO Research Network
 

Viewers also liked (7)

Online Patient Access to their Medical Record and Health Providers is Associa...
Online Patient Access to their Medical Record and Health Providers is Associa...Online Patient Access to their Medical Record and Health Providers is Associa...
Online Patient Access to their Medical Record and Health Providers is Associa...
 
I Got Mine Have you Gotten Yours Email to Promote Colorectal Cancer Screening...
I Got Mine Have you Gotten Yours Email to Promote Colorectal Cancer Screening...I Got Mine Have you Gotten Yours Email to Promote Colorectal Cancer Screening...
I Got Mine Have you Gotten Yours Email to Promote Colorectal Cancer Screening...
 
Use of the Oncology Beacon Module snd Virtusl Dats Warehouse Data to Identify...
Use of the Oncology Beacon Module snd Virtusl Dats Warehouse Data to Identify...Use of the Oncology Beacon Module snd Virtusl Dats Warehouse Data to Identify...
Use of the Oncology Beacon Module snd Virtusl Dats Warehouse Data to Identify...
 
Trend Micro Titanium Antivirus 2012 Review
Trend Micro Titanium Antivirus 2012 ReviewTrend Micro Titanium Antivirus 2012 Review
Trend Micro Titanium Antivirus 2012 Review
 
How to find the Right Contracts & the Right People to Fill Them: Part 4 - Co...
How to find the Right Contracts & the Right People to Fill Them:  Part 4 - Co...How to find the Right Contracts & the Right People to Fill Them:  Part 4 - Co...
How to find the Right Contracts & the Right People to Fill Them: Part 4 - Co...
 
How Important Is Your Blog Design?
How Important Is Your Blog Design?How Important Is Your Blog Design?
How Important Is Your Blog Design?
 
Generalized Anxiety and Depression Among Chronic Pain Patients on Opiod Thera...
Generalized Anxiety and Depression Among Chronic Pain Patients on Opiod Thera...Generalized Anxiety and Depression Among Chronic Pain Patients on Opiod Thera...
Generalized Anxiety and Depression Among Chronic Pain Patients on Opiod Thera...
 

Similar to A Simulated Diabetes Learning Intervention Improves Provider Knowledge and Confidence in Managing Diabetes HILLEN

PSP and ACAD trial.pptx
PSP and ACAD trial.pptxPSP and ACAD trial.pptx
PSP and ACAD trial.pptxNeurologyKota
 
Clinical Trial Simulation training with simulo 20161124
Clinical Trial Simulation training with simulo 20161124Clinical Trial Simulation training with simulo 20161124
Clinical Trial Simulation training with simulo 20161124Ruben Faelens
 
Regenozene Capstone Project Slidedeck
Regenozene Capstone Project SlidedeckRegenozene Capstone Project Slidedeck
Regenozene Capstone Project SlidedeckKawin Koh
 
Dr Andrea Jorgensen - The future of innovation in atrial fibrillation and str...
Dr Andrea Jorgensen - The future of innovation in atrial fibrillation and str...Dr Andrea Jorgensen - The future of innovation in atrial fibrillation and str...
Dr Andrea Jorgensen - The future of innovation in atrial fibrillation and str...Innovation Agency
 
Impactof en feeding protocols
Impactof en feeding protocolsImpactof en feeding protocols
Impactof en feeding protocolsMario Sanchez
 
11 cpg management of jaundice in healthy newborns
11 cpg management of jaundice in healthy newborns11 cpg management of jaundice in healthy newborns
11 cpg management of jaundice in healthy newbornsLily Tensai
 
Digital evidence year in review-2017
Digital evidence year in review-2017Digital evidence year in review-2017
Digital evidence year in review-2017Kent State University
 
AugurixDiagnostic_public profile
AugurixDiagnostic_public profileAugurixDiagnostic_public profile
AugurixDiagnostic_public profileGino Borrelli
 
Build Your Own Nursing Clinical Judgment Question.pptx
Build Your Own Nursing Clinical Judgment Question.pptxBuild Your Own Nursing Clinical Judgment Question.pptx
Build Your Own Nursing Clinical Judgment Question.pptxLucindaStanley
 
To pee or not to pee
To pee or not to peeTo pee or not to pee
To pee or not to peePascale Lane
 
CHRONIC IMMUNE-MEDIATED Demyelinating Neuropathies
CHRONIC IMMUNE-MEDIATED Demyelinating NeuropathiesCHRONIC IMMUNE-MEDIATED Demyelinating Neuropathies
CHRONIC IMMUNE-MEDIATED Demyelinating NeuropathiesMohamed AbdElhady
 
Bi regional je immunzation sri lanka
Bi regional je immunzation  sri lankaBi regional je immunzation  sri lanka
Bi regional je immunzation sri lankalankansikh
 
Outcomes After Intensive Care
Outcomes After Intensive CareOutcomes After Intensive Care
Outcomes After Intensive CareSMACC Conference
 

Similar to A Simulated Diabetes Learning Intervention Improves Provider Knowledge and Confidence in Managing Diabetes HILLEN (20)

PSP and ACAD trial.pptx
PSP and ACAD trial.pptxPSP and ACAD trial.pptx
PSP and ACAD trial.pptx
 
Update on Neurocognitive Complications of HIV Disease
Update on Neurocognitive Complications of HIV DiseaseUpdate on Neurocognitive Complications of HIV Disease
Update on Neurocognitive Complications of HIV Disease
 
ProMEDIC Trial.pptx
ProMEDIC Trial.pptxProMEDIC Trial.pptx
ProMEDIC Trial.pptx
 
Breakout2
Breakout2Breakout2
Breakout2
 
Dr.little mesa 3
Dr.little mesa 3Dr.little mesa 3
Dr.little mesa 3
 
Clinical Trial Simulation training with simulo 20161124
Clinical Trial Simulation training with simulo 20161124Clinical Trial Simulation training with simulo 20161124
Clinical Trial Simulation training with simulo 20161124
 
Regenozene Capstone Project Slidedeck
Regenozene Capstone Project SlidedeckRegenozene Capstone Project Slidedeck
Regenozene Capstone Project Slidedeck
 
Clinician’s Challenge 2011
Clinician’s Challenge 2011Clinician’s Challenge 2011
Clinician’s Challenge 2011
 
Dr Andrea Jorgensen - The future of innovation in atrial fibrillation and str...
Dr Andrea Jorgensen - The future of innovation in atrial fibrillation and str...Dr Andrea Jorgensen - The future of innovation in atrial fibrillation and str...
Dr Andrea Jorgensen - The future of innovation in atrial fibrillation and str...
 
Impactof en feeding protocols
Impactof en feeding protocolsImpactof en feeding protocols
Impactof en feeding protocols
 
evdience based management of nec
evdience based management of necevdience based management of nec
evdience based management of nec
 
11 cpg management of jaundice in healthy newborns
11 cpg management of jaundice in healthy newborns11 cpg management of jaundice in healthy newborns
11 cpg management of jaundice in healthy newborns
 
Digital evidence year in review-2017
Digital evidence year in review-2017Digital evidence year in review-2017
Digital evidence year in review-2017
 
AugurixDiagnostic_public profile
AugurixDiagnostic_public profileAugurixDiagnostic_public profile
AugurixDiagnostic_public profile
 
Build Your Own Nursing Clinical Judgment Question.pptx
Build Your Own Nursing Clinical Judgment Question.pptxBuild Your Own Nursing Clinical Judgment Question.pptx
Build Your Own Nursing Clinical Judgment Question.pptx
 
To pee or not to pee
To pee or not to peeTo pee or not to pee
To pee or not to pee
 
Study designs
Study designsStudy designs
Study designs
 
CHRONIC IMMUNE-MEDIATED Demyelinating Neuropathies
CHRONIC IMMUNE-MEDIATED Demyelinating NeuropathiesCHRONIC IMMUNE-MEDIATED Demyelinating Neuropathies
CHRONIC IMMUNE-MEDIATED Demyelinating Neuropathies
 
Bi regional je immunzation sri lanka
Bi regional je immunzation  sri lankaBi regional je immunzation  sri lanka
Bi regional je immunzation sri lanka
 
Outcomes After Intensive Care
Outcomes After Intensive CareOutcomes After Intensive Care
Outcomes After Intensive Care
 

More from HMO Research Network

New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...
New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...
New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...HMO Research Network
 
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...HMO Research Network
 
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...HMO Research Network
 
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...HMO Research Network
 
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGER
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGERA Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGER
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGERHMO Research Network
 
The Use of Administrative Data and Natural Language Processing to Estimate th...
The Use of Administrative Data and Natural Language Processing to Estimate th...The Use of Administrative Data and Natural Language Processing to Estimate th...
The Use of Administrative Data and Natural Language Processing to Estimate th...HMO Research Network
 
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...HMO Research Network
 
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...HMO Research Network
 
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...HMO Research Network
 
An Application of Doubly Robust Estimation JOHNSON
An Application of Doubly Robust Estimation JOHNSONAn Application of Doubly Robust Estimation JOHNSON
An Application of Doubly Robust Estimation JOHNSONHMO Research Network
 
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...HMO Research Network
 
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOK
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOKExpanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOK
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOKHMO Research Network
 
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...HMO Research Network
 
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...Feasibility of Implementing Screening Brief Intervention and Referral to Trea...
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...HMO Research Network
 
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...HMO Research Network
 
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...A Telephone Based Diabetes Prevention Program and Social Support for Weight L...
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...HMO Research Network
 
Technological Resources & Personnel Costs Required to Implement an Automated ...
Technological Resources & Personnel Costs Required to Implement an Automated ...Technological Resources & Personnel Costs Required to Implement an Automated ...
Technological Resources & Personnel Costs Required to Implement an Automated ...HMO Research Network
 
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALE
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALEDocumentations of Advanced Heath Care Directives Where Are They TAI_SEALE
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALEHMO Research Network
 
A Simulated Diabetes Learning Intervention Improves Provider Knowledge and Co...
A Simulated Diabetes Learning Intervention Improves Provider Knowledge and Co...A Simulated Diabetes Learning Intervention Improves Provider Knowledge and Co...
A Simulated Diabetes Learning Intervention Improves Provider Knowledge and Co...HMO Research Network
 

More from HMO Research Network (20)

New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...
New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...
New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...
 
From Populations to Patients
From Populations to PatientsFrom Populations to Patients
From Populations to Patients
 
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...
 
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...
 
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...
 
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGER
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGERA Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGER
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGER
 
The Use of Administrative Data and Natural Language Processing to Estimate th...
The Use of Administrative Data and Natural Language Processing to Estimate th...The Use of Administrative Data and Natural Language Processing to Estimate th...
The Use of Administrative Data and Natural Language Processing to Estimate th...
 
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...
 
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...
 
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...
 
An Application of Doubly Robust Estimation JOHNSON
An Application of Doubly Robust Estimation JOHNSONAn Application of Doubly Robust Estimation JOHNSON
An Application of Doubly Robust Estimation JOHNSON
 
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...
 
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOK
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOKExpanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOK
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOK
 
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
 
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...Feasibility of Implementing Screening Brief Intervention and Referral to Trea...
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...
 
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...
 
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...A Telephone Based Diabetes Prevention Program and Social Support for Weight L...
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...
 
Technological Resources & Personnel Costs Required to Implement an Automated ...
Technological Resources & Personnel Costs Required to Implement an Automated ...Technological Resources & Personnel Costs Required to Implement an Automated ...
Technological Resources & Personnel Costs Required to Implement an Automated ...
 
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALE
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALEDocumentations of Advanced Heath Care Directives Where Are They TAI_SEALE
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALE
 
A Simulated Diabetes Learning Intervention Improves Provider Knowledge and Co...
A Simulated Diabetes Learning Intervention Improves Provider Knowledge and Co...A Simulated Diabetes Learning Intervention Improves Provider Knowledge and Co...
A Simulated Diabetes Learning Intervention Improves Provider Knowledge and Co...
 

A Simulated Diabetes Learning Intervention Improves Provider Knowledge and Confidence in Managing Diabetes HILLEN

  • 1. A Simulated Diabetes Learning Intervention Improves Provider Knowledge and Confidence in Managing Diabetes JoAnn Sperl-Hillen, MD Co-director of Center for Chronic Care Innovation HealthPartners Research Foundation, Minneapolis, MN Wednesday May 2, 2012 8-9:30am 18th Annual HMO Research Network Conference Seattle, WA Accelerating excellence in health performance through education, advocacy, and collaboration
  • 2. Team Members  JoAnn Sperl-Hillen  Steve Asche  Patrick O’Connor  George Biltz*  Heidi Ekstrom  Deb Curran  William Rush  Paul Johnson*  Omar Fernandes  Andrew Rudge  Jerry Amundson  Todd Gilmer**  Deepika Appana HealthPartners Research Foundation and HealthPartners Institute for Medical Education, Minneapolis, MN; * Carlson School of Management, University of Minnesota, Minneapolis MN; ** Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA
  • 3. Presenter Disclosures  NIH research support  Listed inventor on a U.S. patent application filed related to simulation technology  HPRF has recently entered into a royalty-bearing license agreement with a third party to commercialize the simulated learning technology for the purpose of broader dissemination.  Non-paid director on the board of directors for that licensee (SimCare Health)
  • 4. Why is provider training needed?  Provider performance varies, even within the same clinic populations  Clinical inertia is common, particularly for insulin treatment  Provider knowledge varies  The cognitive processes and tasks related to diabetes are complex
  • 5. Barriers to Provider Training  Time constraints  Lack of continuity experiences  Relatively limited ambulatory experience in residency training  Complicated diseases with need for personalization of care  Experts & opinion leaders are often not available or affordable, and teaching is difficult to standardize
  • 6. What is simulation? ―Simulation is a technique—not a technology—to replace or amplify real experiences with guided experiences that evoke or replicate substantial aspects of the real world in a fully interactive manner.‖ Gaba (2004) History of Simulation Aviation NASA Military Medical 1960s First Mannequin: Resusci-Annie 1960s-70s Computer-assisted learning program in medicine 1990 High fidelity mannequins become available
  • 7. What are the advantages to simulation?  Efficient & cost effective  Sustainable & standardized  In line with adult learning principles  Personalized (case-based). Case-based simulations provide a context for learning  People are more likely to remember learning and replicate in real-world situations.  Capture the importance of continuity of care  Proven satisfaction & effectiveness
  • 8. Elements needed to create a simulated learning program 1. Identify the learning needs and create a library of case scenarios 2. Create an interactive web-interface 3. Model and program the physiology 4. Program the feedback – to critique action the provider takes between encounters
  • 9. Demo of SimCare available at www.simcarediabetes.org Patient “snapshot” screen shot
  • 12. Early SimCare Study Funding through R01HS10639, Physician Intervention to Improve Diabetes Care  57 consented PCP’s and their 2,020 patients.  Randomized to one of 3 groups:  (A) no intervention  (B) learning intervention (SimCare) consisting of 3 simulated learning cases (1 hr)  (C) SimCare + physician opinion leader  Results:  SimCare reduced risky prescribing of metformin in patients with renal impairment (p=0.03).  Group B (SimCare alone) achieved slightly better glycemic control than A or C (p=.04)
  • 13. SimCare Version 2 Funding through R01DK068314, Reducing Clinical Inertia in Diabetes  Eleven clinics with 41 consenting PCP’s  Randomized to receive or not receive an improved version of SimCare (12 cases assigned based on profiled ―needs‖, 3 hrs)  Results: Patients of intervention providers with baseline A1c > 7% had significantly greater A1c reduction (-.19%) relative to patients of non-intervention providers.
  • 14. SimCare Version 3 Funding through R18DK079861, Simulated Diabetes Training for Resident Physicians 19 eligible residency programs linked to 723 residents 382 residents did not consent 341 residents consented Intervention – Early learning 10) Control – Late learning (9) Residents (177) Residents (164) Completion rates Completion rates Learning cases (142) Assessment cases (135) Assessment cases (97) Knowledge survey (128) Knowledge survey (92) Evaluation (94)
  • 15. Implementing the learning program  Residents at 19 programs were given a brochure that we provided and asked to sign up online  Resident participation was voluntary.  Time commitment – 18 cases, 1 hour/month for 8 months if randomized to the early intervention group  Incentives - $50 Target gift card on completion of the assigned tasks  Promotions – 4 iPad raffle promotions and 1 Target gift card promotion to achieve acceptable learning and assessment case completion rates
  • 16. Baseline characteristics of residents Intervention Control P-value (n=92) (n=128) % female 48% 57% 0.31 % white 48% 58% 0.41 Age (median) 29 29 0.69 Specialty Family Medicine 34% 49% Internal Medicine 54% 42% 0.15 Med-Peds 8% 7% Other 4% 2% Post graduate year 35% 34% 1 36% 34% 2 0.70 28% 28% 3 1% 4% 4
  • 17. Example Knowledge Question 2. A 77 year old black man is seeing you for follow up. He has a 13 year history of type 2 diabetes, coronary heart disease (CABG at age 58), chronic stable angina, and dyslipidemia. He has been eating out a lot and gaining weight. His current medications are metformin 1000 mg bid, atenolol 50 mg qd, and simvastatin 40 mg qd. His BMI is 37, BP is 165/86, A1c 9.3%, Cr 2. 2 mg/dl, eGFR 28, LDL 94 mg/dl, HDL 36 mg/dl, and TG 278 mg/dl. Which of the following would be your MOST likely recommended action? A. Start basal insulin and treat to an A1c goal of < 7%. No change in other glycemia medications. B. Discontinue metformin and start basal insulin. Follow up with patient for insulin adjustments with an A1c goal of < 7%. C. Start basal insulin and follow up with the patient for insulin adjustments with an A1c goal of < 8%. No change in other glycemia medications. D. Discontinue metformin and start basal insulin. Follow up with patient for insulin adjustments with an A1c goal of < 8%. E. No change now because I would address other patient problems Correct answer D (59% intervention, 26% control)
  • 18. P- Q# Knowledge topics covered Early Late value 1 Screen for DM (using an A1c) 75.0 75.8 .894 2 Basal insulin start, individualized A1c goal < 8% 58.7 25.8 <.0001 Check ketones in newly diagnosed symptomatic patients & 3 31.5 28.1 .586 start insulin Reduce basal insulin due to nocturnal hypoglycemia 4 64.1 70.3 .333 (Somogyii) 5 Relax A1c target due to hypoglycemia unawareness 57.6 32.8 .0002 6 Start insulin in a newly diagnosed symptomatic patient 33.7 11.7 <.0001 Use of a loop diuretic rather than thiazide in patient with renal 7 insufficiency. Fenofibrate not beneficial in addition to statin. 44.6 19.5 <.0001 DC metformin due to renal contraindication. Initiate BP tx (without confirmatory testing) if BP > 180/100. 8 59.8 44.5 0.026 Statins may be helpful for most patients with DM. 9 Start a statin, screen for depression, basal insulin start 66.3 57.0 .164 Geriatric polypharmacy concerns, depression screening, 10 46.7 41.4 .431 hypoglycemia management, statin use in the elderly
  • 19. Results of Knowledge Testing Number of items Intervention Control correct out of 10 0-4 29% 66% 5-7 60% 32% 8-10 11% 2% Mean score 5.31 4.10 p < .001 (95% CI) (4.87-5.75) (3.69-4.50) N=220 completers of knowledge survey
  • 20. Results of self-rated confidence and knowledge about diabetes management Topic Intervention Control P-value How knowledgeable are you about how to use all available drug classes to manage 61 25 <.001 patients with diabetes? How knowledgeable are you about how to 83 45 <.001 start and adjust insulin? How knowledgeable are you about interpreting patient self-monitored glucose 85 59 .009 values (SMBGs)? How knowledgeable are you about setting individualized treatment goals for people 83 44 <.001 with diabetes? How confident are you in managing patients 79 44 <.001 with diabetes?
  • 21. Evidence for learning transfer to actual patient care  77% applied learning to actual patients  63% shortened visit intervals  78% more likely to add or increase drugs if patient is not at goal  92% more confident about insulin use in actual patients ….and results of two trials had demonstrated improved outcomes of actual patients of practicing providers who used earlier versions of SimCare
  • 22. Study limitations  Voluntary participation, not all completed the learning program and completed evaluations  No outcome data on non-completers  Survey completion rates were lower in the intervention (52%) than the control groups (78%)  No actual patient data to evaluate  Assessment case outcomes not yet available
  • 23. Thank you! For additional questions, please contact…  JoAnn Sperl-Hillen: joann.m.sperlhillen@healthpartners.com  Patrick O’Connor: patrick.j.oconnor@healthpartners.com  Heidi Ekstrom: heidi.l.ekstrom@healthpartners.com
  • 24. Talk References  Simulated Physician Learning Intervention to Improve Safety and Quality of Diabetes Care: A Randomized Trial O’Connor PJ, Sperl-Hillen JM, et al. Simulated physician learning intervention to improve safety and quality of diabetes care: A Randomized Trial. Diabetes Care. 2009;32(4): 585-590.  Simulated Physician Learning Program Improves Glucose Control in Adults with Diabetes Sperl-Hillen JM, O’Connor PJ, Rush WA, Johnson PE, Gilmer TP, Biltz G, Asche SE, Ekstrom HL. Simulated Physician Learning Program Improves Glucose Control in Adults with Diabetes. Diabetes Care. 2010;33(8): 1727-1733.

Editor's Notes

  1. Knowledge - Knowing the right thing to doComplexity of cognitive processes and tasks related to diabetesPrioritization - Addressing competing clinical prioritiesAbility to anticipate treatment effects &amp; determine the best follow-up intervalSafety and monitoring routines - Avoiding potential safety hazardsLack of guideline consensus on goals makes is also a reason
  2. High clinical inertia ratesProvider performance variability
  3. In general terms, simulation is a technique or device that attempts to create characteristics of the real world. In health care, simulation may refer to a device representing a simulated patient or part of a patient. Such a device can respond to and interact with the actions of the learner. Simulation also refers to activities that mimic the reality of a clinical environment and that are designed for use in demonstrating procedures and promoting decisionmaking and critical thinking. In health care education, simulation can take many forms, from relatively simple to highly complex Medical simulation has its foundations in aviation, the military and industry.A flight simulator was developed in the 1920s to create an easier, safer and less expensive way to learn how to fly, but it wasn’t until after several catastrophic events in the ‘30s that the military purchased several of these “Link trainers”. Military needs during WWII increased usage &amp; initiated the development of additional simulators. In the 1950s the FAA required simulation recertification to maintain commercial pilots’ licenses. In the 1970s, NASA used simulations to bring the Apollo 13 crew home. Later in the 1970s, human factors were recognized as the source of many events and the concepts of cockpit or crew resource management were formed. Use of simulation in these industries have continued to grow. Modern medical simulation started much later, in the 60’s with the first resuscitation mannequin. By the end of the decade, Harvey, a cardiology mannequin was launched. A rudimentary computer program was also developed for medical education. Since the 1990s simulation in healthcare has exploded and new simulators are in development.
  4. Simulation allows health care providers to develop their skills without endangering the patient or affecting their own self confidence. Because a situation or encounter is simulated, it can be re-run, stopped or altered for improved educational value. This creates a learning environment where multiple options can be practiced and cognitive or psychomotor skills mastered.Simulation-based education has been proven to be effective in industry, aviation, the military and healthcare. There are a plethora of publications describing its application in healthcare in the areas of emergency management, procedural skills, obstetrics, surgery, teamwork &amp; communication. Little has been published on its use in chronic disease management.So why do it? In some applications, like this interactive computer-based simulation program, it is efficient &amp; cost effective…Case-based simulations provide a context for learningPeople are more likely to remember learning and replicate in real-world situations.Provides chart encounters of simulated patients in a primary care environment.Simulation depicts some aspect of reality where the learner can identify and study the effects of change.
  5. The design of the intervention concentrated on four elements described in more detail below: 1. A comprehensive library of case scenarios of patients with type 1 and type 2 diabetes.A team of experts that included physicians proficient in current diabetes guidelines and treatment, a professor of medical physiology, and a professor of decision-making science collaborated regularly to design a clinical content map of diabetes management that would comprehensively address care skills deemed important for resident providers to learn. Table 1 is a list of the learning principles that emerged on the map within the domains of glycemia, lipids, blood pressure, and safety and monitoring. Next, 18 cases were developed with initialized scenarios and patient states that would facilitate provider learning pertaining to all learning topics on the clinical content map.2. An interactive web-based interface display for providers to manage the simulated cases. A web-based interface was designed to mimic an electronic health record. It allowed for complex medical scenarios to come alive through narrative and information displayed in the patient’s “chart,” and for users to perform multiple clinical functions such as review the chart history, prescribe medications, start and adjust insulin with each meal and at bedtime, order labs and diagnostic tests such as electrocardiograms, chest x-rays and sleep studies, make referrals, give patient advice, view self-monitored blood sugar (SMBG) results and change SMBG frequency, and schedule phone or visit follow-up at any desired frequency. See figure 1 for a screen shot of the interface.3. A physiologic model (or engine) to calculate effects of provider actions.Formulas derived from published literature and clinical experts were modeled to compute physiologic responses to provider actions. For example, the simulated patient’s blood sugar state was represented by 8 self-monitored blood sugar (SMBG) values or “patient states” throughout the day. Short and long-acting Insulin and oral drug effects were based on pharmacokinetic curves that distribute the SMBG effects of the drugs over time. Other clinical states that were modeled included blood pressure, pulse, weight, lipids, renal function, potassium, microalbuminuria, depression, drug and behavioral adherence. The collection of patient clinical state predictors were stacked in a predefined way and could be added to in a plug and play fashion to extend to new domains and patient states. The simulation engine was developed using a Java  application running on Linux  servers, and the data was stored in an Oracle  Database. 3. A physiologic model (or engine) to calculate effects of provider actions.Formulas derived from published literature and clinical experts were modeled to compute physiologic responses to provider actions. For example, the simulated patient’s blood sugar state was represented by 8 self-monitored blood sugar (SMBG) values or “patient states” throughout the day. Short and long-acting Insulin and oral drug effects were based on pharmacokinetic curves that distribute the SMBG effects of the drugs over time. Other clinical states that were modeled included blood pressure, pulse, weight, lipids, renal function, potassium, microalbuminuria, depression, drug and behavioral adherence. The collection of patient clinical state predictors were stacked in a predefined way and could be added to in a plug and play fashion to extend to new domains and patient states. The simulation engine was developed using a Java  application running on Linux  servers, and the data was stored in an Oracle  Database.  
  6. Example of a patient with type 2 diabetes of 5 years duration
  7. Knowledge test was completed by 52% of early and 78% late intervention participants
  8. We ran an analysis looking at change in these questions from baseline to follow up (to account for the higher ratings on self-efficacy at baseline in the intervention group compared to the control group) and had similar findings. Everything remained significantly improved in the intervention group.
  9. simCare: 57 consented docs and 2000 of their patients. 2001. Better glycemic control and reductions in risky prescribing of metformin in patients with renal impairment-DM inertia: 41 consenting docsand 3000 patients, Conducted 2006-07, better mean A1c and higher % of patients at goal. Costs trended lower -$71 per patient relative to non-intervention patients.